Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.
Harris SA, White A, Stockdale L, Tanner R, Sibley L, Sarfas C, Meyer J, Peter J, O'Shea MK, Manjaly Thomas ZR, Hamidi A, Satti I, Dennis MJ, McShane H, Sharpe S. Harris SA, et al. Among authors: hamidi a. Tuberculosis (Edinb). 2018 Jan;108:99-105. doi: 10.1016/j.tube.2017.11.006. Epub 2017 Nov 15. Tuberculosis (Edinb). 2018. PMID: 29523335 Free PMC article.
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Manjaly Thomas ZR, Satti I, Marshall JL, Harris SA, Lopez Ramon R, Hamidi A, Minhinnick A, Riste M, Stockdale L, Lawrie AM, Vermaak S, Wilkie M, Bettinson H, McShane H. Manjaly Thomas ZR, et al. Among authors: hamidi a. PLoS Med. 2019 Apr 30;16(4):e1002790. doi: 10.1371/journal.pmed.1002790. eCollection 2019 Apr. PLoS Med. 2019. PMID: 31039172 Free PMC article. Clinical Trial.
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Wilkie M, Satti I, Minhinnick A, Harris S, Riste M, Ramon RL, Sheehan S, Thomas ZM, Wright D, Stockdale L, Hamidi A, O'Shea MK, Dwivedi K, Behrens HM, Davenne T, Morton J, Vermaak S, Lawrie A, Moss P, McShane H. Wilkie M, et al. Among authors: hamidi a. Vaccine. 2020 Jan 22;38(4):779-789. doi: 10.1016/j.vaccine.2019.10.102. Epub 2019 Nov 15. Vaccine. 2020. PMID: 31735500 Free PMC article. Clinical Trial.
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Wilkie M, Tanner R, Wright D, Lopez Ramon R, Beglov J, Riste M, Marshall JL, Harris SA, Bettencourt PJG, Hamidi A, van Diemen PM, Moss P, Satti I, Wyllie D, McShane H. Wilkie M, et al. Among authors: hamidi a. Sci Rep. 2022 May 12;12(1):7808. doi: 10.1038/s41598-022-11748-x. Sci Rep. 2022. PMID: 35552463 Free PMC article. Clinical Trial.
Bibliometric Analysis of Human Metapneumovirus Studies.
Alıravcı ID, Çelik T, Çelik-Ekinci S, Hamidi AA. Alıravcı ID, et al. Among authors: hamidi aa. Infect Dis Clin Microbiol. 2023 Dec 29;5(4):311-322. doi: 10.36519/idcm.2023.250. eCollection 2023 Dec. Infect Dis Clin Microbiol. 2023. PMID: 38633850 Free PMC article.
Exploring the OTITIS Research Landscape Through a Scientometric Approach.
Akhlaghi A, Hashemi SB, Hamidi A, Khosravi A, Jahangiri R. Akhlaghi A, et al. Among authors: hamidi a. Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1697-1710. doi: 10.1007/s12070-023-04387-9. Epub 2023 Dec 9. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 38566640
208 results